Biomerica (BMRA) Competitors $2.88 +0.02 (+0.56%) As of 01:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BMRA vs. QTTB, DARE, PMN, KZR, CVKD, ENLV, XCUR, LPTX, MTVA, and ALLRShould you be buying Biomerica stock or one of its competitors? The main competitors of Biomerica include Q32 Bio (QTTB), Dare Bioscience (DARE), Promis Neurosciences (PMN), Kezar Life Sciences (KZR), Cadrenal Therapeutics (CVKD), Enlivex Therapeutics (ENLV), Exicure (XCUR), Leap Therapeutics (LPTX), MetaVia (MTVA), and Allarity Therapeutics (ALLR). These companies are all part of the "pharmaceutical products" industry. Biomerica vs. Its Competitors Q32 Bio Dare Bioscience Promis Neurosciences Kezar Life Sciences Cadrenal Therapeutics Enlivex Therapeutics Exicure Leap Therapeutics MetaVia Allarity Therapeutics Q32 Bio (NASDAQ:QTTB) and Biomerica (NASDAQ:BMRA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends. Does the media favor QTTB or BMRA? In the previous week, Biomerica had 5 more articles in the media than Q32 Bio. MarketBeat recorded 8 mentions for Biomerica and 3 mentions for Q32 Bio. Biomerica's average media sentiment score of 0.84 beat Q32 Bio's score of 0.63 indicating that Biomerica is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Q32 Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Biomerica 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, QTTB or BMRA? Q32 Bio has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Comparatively, Biomerica has a beta of 0.34, meaning that its stock price is 66% less volatile than the S&P 500. Is QTTB or BMRA more profitable? Q32 Bio has a net margin of 0.00% compared to Biomerica's net margin of -74.84%. Biomerica's return on equity of -74.32% beat Q32 Bio's return on equity.Company Net Margins Return on Equity Return on Assets Q32 BioN/A -2,709.70% -61.16% Biomerica -74.84%-74.32%-53.24% Which has better earnings and valuation, QTTB or BMRA? Biomerica has higher revenue and earnings than Q32 Bio. Biomerica is trading at a lower price-to-earnings ratio than Q32 Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQ32 Bio$1.16M37.18-$47.73M-$4.30-0.82Biomerica$5.31M1.55-$4.97M-$2.32-1.24 Do institutionals & insiders have more ownership in QTTB or BMRA? 31.3% of Q32 Bio shares are owned by institutional investors. Comparatively, 22.3% of Biomerica shares are owned by institutional investors. 40.0% of Q32 Bio shares are owned by company insiders. Comparatively, 15.0% of Biomerica shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts rate QTTB or BMRA? Q32 Bio currently has a consensus price target of $12.17, indicating a potential upside of 244.18%. Given Q32 Bio's stronger consensus rating and higher probable upside, analysts plainly believe Q32 Bio is more favorable than Biomerica.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Q32 Bio 1 Sell rating(s) 6 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.11Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryQ32 Bio and Biomerica tied by winning 8 of the 16 factors compared between the two stocks. Get Biomerica News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BMRA vs. The Competition Export to ExcelMetricBiomericaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.27M$3.02B$6.15B$10.48BDividend YieldN/A57.77%5.73%4.78%P/E Ratio-1.2422.9884.9827.27Price / Sales1.55625.64574.66178.17Price / CashN/A172.6337.3961.86Price / Book1.795.4612.456.71Net Income-$4.97M$33.06M$3.32B$276.79M7 Day Performance-2.51%-0.96%0.28%-0.77%1 Month Performance-4.13%13.17%10.12%6.38%1 Year Performance5.67%-2.14%72.36%37.91% Biomerica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BMRABiomerica0.4267 of 5 stars$2.88+0.6%N/A+11.3%$8.27M$5.31M-1.2460News CoverageUpcoming EarningsAnalyst ForecastGap DownHigh Trading VolumeQTTBQ32 Bio2.9704 of 5 stars$2.52+16.1%$12.17+382.8%-92.5%$30.74M$1.16M-0.5939News CoverageAnalyst ForecastHigh Trading VolumeDAREDare Bioscience1.9794 of 5 stars$2.24-0.4%$10.00+346.4%-41.6%$30.20M$10K-1.0530Positive NewsPMNPromis Neurosciences3.3261 of 5 stars$0.54-1.4%$4.33+701.0%-54.1%$29.11MN/A-2.585KZRKezar Life Sciences3.7533 of 5 stars$3.86-1.8%$9.00+133.2%-50.6%$28.27MN/A-0.4060High Trading VolumeCVKDCadrenal Therapeutics2.3757 of 5 stars$13.62+0.7%$32.00+134.9%-3.0%$27.92MN/A-1.534News CoverageENLVEnlivex Therapeutics2.7231 of 5 stars$1.13-1.3%$10.00+785.0%-25.2%$27.45MN/A-1.9570XCURExicure1.741 of 5 stars$4.31+0.9%N/A+126.2%$27.24M$500K-1.1150Gap UpLPTXLeap Therapeutics2.4541 of 5 stars$0.63-18.0%$3.38+438.8%-72.8%$25.96MN/A-0.4040Gap DownHigh Trading VolumeMTVAMetaVia2.8244 of 5 stars$1.06-1.9%$7.50+607.5%N/A$25.65MN/A0.008ALLRAllarity Therapeutics2.7556 of 5 stars$1.75+6.1%$9.25+428.6%-9.6%$25.41MN/A0.0010 Related Companies and Tools Related Companies Q32 Bio Alternatives Dare Bioscience Alternatives Promis Neurosciences Alternatives Kezar Life Sciences Alternatives Cadrenal Therapeutics Alternatives Enlivex Therapeutics Alternatives Exicure Alternatives Leap Therapeutics Alternatives MetaVia Alternatives Allarity Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BMRA) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredThe Final DisplacementA new documentary called The Final Displacement is stirring major controversy — and for good reason. It expose...Porter & Company | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomerica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomerica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
